UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 206

Sortiert nach

Modern Therapy of Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2011-02, Vol.29 (5), p.532-543

2011

Volltextzugriff (PDF)

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

The New England journal of medicine, 2017-03, Vol.376 (9), p.836-847

2017

Volltextzugriff (PDF)

Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challenges

Journal of hematology and oncology, 2019-04, Vol.12 (1), p.39-39, Article 39

2019

Volltextzugriff (PDF)

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

The New England journal of medicine, 2020-10, Vol.383 (17), p.1613-1623

2020

Volltextzugriff (PDF)

Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment

European journal of haematology, 2016-05, Vol.96 (5), p.447-460

2016

Volltextzugriff (PDF)

Diagnosis and subclassification of acute lymphoblastic leukemia

Mediterranean journal of hematology and infectious diseases, 2014-01, Vol.6 (1), p.e2014073-e2014073

2014

Volltextzugriff (PDF)

International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

Haematologica (Roma), 2016-12, Vol.101 (12), p.1524

2016

Volltextzugriff (PDF)

Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population

Therapeutic Advances in Hematology, 2020-01, Vol.11, p.2040620720903531-2040620720903531

2020

Volltextzugriff (PDF)

Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913

Haematologica (Roma), 2021-06, Vol.106 (6), p.1559

2021

Volltextzugriff (PDF)

Lymphoblastic Lymphoma: a Concise Review

Current oncology reports, 2022, Vol.24 (1), p.1-12

2022

Volltextzugriff (PDF)

National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?

BMC cancer, 2020-10, Vol.20 (1), p.956-12, Article 956

2020

Volltextzugriff (PDF)

Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07

Blood cancer journal (New York), 2020-11, Vol.10 (11), p.119-119, Article 119

2020

Volltextzugriff (PDF)

Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00

Journal of clinical oncology, 2010-08, Vol.28 (22), p.3644-3652

2010

Volltextzugriff (PDF)

Quality of Response in Acute Myeloid Leukemia: The Role of Minimal Residual Disease

Cancers, 2019-09, Vol.11 (10), p.1417

2019

Volltextzugriff (PDF)

Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study

Blood cancer journal (New York), 2023-01, Vol.13 (1), p.2-2, Article 2

2023

Volltextzugriff (PDF)

Evaluation of Environmental Influences on a Multi-Point Optical Fiber Methane Leak Monitoring System

Remote sensing (Basel, Switzerland), 2019-05, Vol.11 (10), p.1249

2019

Volltextzugriff (PDF)

Using Minimal Residual Disease to Improve Treatment Response Definitions and Hematopoietic Cell Transplantation Strategy in Acute Leukemia

Journal of clinical oncology, 2016-02, Vol.34 (4), p.300-302

Bassan, Renato

2016

Volltextzugriff (PDF)

Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival

Haematologica (Roma), 2016-06, Vol.101 (6), p.e245

2016

Volltextzugriff (PDF)

Electroless Nickel-Plating Sealing in FBG Pressure Sensor for Thermoelectric Power Plant Engines Applications

Journal of lightwave technology, 2019-09, Vol.37 (18), p.4791-4798

2019

Volltextzugriff (PDF)

Capture-Based Next-Generation Sequencing Improves the Identification of Immunoglobulin/T-Cell Receptor Clonal Markers and Gene Mutations in Adult Acute Lymphoblastic Leukemia Patients Lacking Molecular Probes

Cancers, 2020-06, Vol.12 (6), p.1505

2020

Volltextzugriff (PDF)

Reply to C.S. Hourigan et al

Journal of clinical oncology, 2016-07, Vol.34 (21), p.2559-2560

Bassan, Renato

2016

Volltextzugriff (PDF)

MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL

Cancers, 2021-04, Vol.13 (9), p.2108

2021

Volltextzugriff (PDF)

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(185)
Mit Volltextzugriff
(160)

Publikationsform

Artikel
(203)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(128)
Life Sciences & Biomedicine
(120)
Humans
(116)
Hematology
(86)
Adult
(77)
Male
(74)
Female
(73)
Middle Aged
(73)
Oncology
(50)
Aged
(48)
Biological And Medical Sciences
(44)
Medical Sciences
(43)
Adolescent
(40)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(35)
Hematologic And Hematopoietic Diseases
(30)
Prognosis
(26)
Acute Lymphoblastic Leukemia
(25)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(25)
Treatment Outcome
(25)
Remission Induction
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Modern Therapy of Acute Lymphoblastic Leukemia

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challenges

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment

Diagnosis and subclassification of acute lymphoblastic leukemia

International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population

Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913

Lymphoblastic Lymphoma: a Concise Review

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?

Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07

Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00

Quality of Response in Acute Myeloid Leukemia: The Role of Minimal Residual Disease

CEBPA -double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features

Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study

Evaluation of Environmental Influences on a Multi-Point Optical Fiber Methane Leak Monitoring System

Using Minimal Residual Disease to Improve Treatment Response Definitions and Hematopoietic Cell Transplantation Strategy in Acute Leukemia

Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival

Electroless Nickel-Plating Sealing in FBG Pressure Sensor for Thermoelectric Power Plant Engines Applications

Capture-Based Next-Generation Sequencing Improves the Identification of Immunoglobulin/T-Cell Receptor Clonal Markers and Gene Mutations in Adult Acute Lymphoblastic Leukemia Patients Lacking Molecular Probes

Reply to C.S. Hourigan et al

MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL

Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia

Suchergebnisse filtern